Abstract:ObjectiveTo investigate the value of combined measurement of alpha-fetoprotein (AFP) and AFP-L3% in the diagnosis of hepatocellular carcinoma (HCC). MethodsA retrospective analysis was performed for serological parameters and clinical data of 1208 patients with chronic hepatitis, 1967 patients with liver cirrhosis, and 1569 patients with primary HCC who attended The Fifth Medical Center of Chinese PLA General Hospital from January 2010 to December 2017. The distribution of serum AFP and AFP-L3% was analyzed, and AFP alone, AFP-L3% alone, and AFP combined with AFP-L3% were compared in terms of sensitivity, specificity, and area under the receiver operating characteristic curve (AUC). The correlation of AFP with AFP-L3 level and AFP-L3% was also analyzed. A one-way analysis of variance or the Kruskal-Wallis H test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. The Spearman rank correlation test was used for correlation analysis of continuous data, the Delong test was used for comparison of AUC, and logistic regression was used to establish the model of AFP combined with AFP-L3% for the diagnosis of HCC. ResultsThe HCC group had significantly higher serum levels of AFP and AFP-L3 than the liver cirrhosis group and the chronic hepatitis group (H=1107.3 and 1076.9, both P＜0.01). The HCC group had a significantly higher positive rate of AFP-L3% than the liver cirrhosis group and the chronic hepatitis group (30.9% vs 3.0%/2.8%, P＜0.01). The HCC group had a significantly higher level of AFP-L3 than the liver cirrhosis group and the chronic hepatitis group （3.3(0-13.4)% vs 0/0, H=1034.1, P＜001）. The correlation analysis showed that serum AFP was significantly correlated with AFP-L3 level (r=0.91, P＜0.01), and there was no correlation between AFP-L3% and AFP (r=0.04, P＞0.05). With specificity remaining the same, AFP combined with AFP-L3% had a significantly higher sensitivity in the diagnosis of HCC than AFP alone (26.6% vs 18.4%, P＜0.01) or AFP-L3% alone (36.6% vs 30.9%, P＜0.01). The subgroup analysis showed that for the samples with AFP ≥10 μg/L, AFP combined with AFP-L3% had a significantly higher AUC in the diagnosis of HCC than AFP alone (0.745 vs 0.701, P＜0.01); for the tumor with a diameter of ＞2 cm or hepatitis B-related liver cancer, AFP combined with AFP-L3% had a significantly higher sensitivity than AFP alone (27.6% vs 180%/27.7% vs 19.1%, both P＜0.01) or AFP-L3% alone (37.0% vs 30.3%/36.9% vs 31.8%, both P＜0.01). For the group with a tumor diameter of ≤2 cm and the group without hepatitis B-related liver cancer, there was no significant difference in sensitivity between AFP combined with AFP-L3% and AFP or AFP-L3% alone in the diagnosis of HCC (all P＞0.05). ConclusionAFP combined with AFP-L3% can significantly improve the sensitivity of HCC diagnosis and has a good clinical value in the diagnosis of hepatitis B-related liver cancer and liver cancer with a tumor diameter of ＞2 cm.

Relationship between GP73,CEA, AFP-L3 and HBV-DNA, and their diagnostic value in the classification in patients with liver cirrhosis

Combined determination of serum DCP, GPC3 and HSP70 in diagnosis of AFP-negative primary liver carcinoma

Value of GPC3, GP73, AFP-L3 and AFP detection in the diagnosis of primary hepatic carcinoma

Assessment of serum GP73, AFP-L3, AFP and AFU detection in the diagnosis of hepatocellular carcinoma

Correlative Analysis of the Hepatitis B Serological Biomarkers with Serum Liver Fibrosis Biomarkers

Expression of GP73 in Liver Cirrhosis and Its Assistant Value in Grading of Liver Cirrhosis

Relationship Between HBV and AFP and Liver Function in PHC

Combined Detection of Liver Stiffness and C-reactive Protein in Patients with Hepatitis B Virus-Related Liver Cirrhosis, with and Without Hepatocellular Carcinoma.

Clinical Significance of Serum GP73,DCP,GPC-3 and AFP Tests in Diagnosis of Primary Hepatic Carcinoma

Quantitative PCR-based high-sensitivity detection of HBV-DNA levels reflects liver function deterioration in patients with hepatitis B virus-related cirrhosis

Clinical Application Value of Chitinase-3-like Protein 1 in Patients with Different Liver Diseases

Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma.

Value of combined measurement of alpha-fetoprotein and alpha-fetoprotein L3％in the diagnosis of hepatocellular carcinoma

[Clinical Application of Serum Golgi Protein 73 in the Diagnosis and Progress of Hepatocellular Carcinoma].

Clinical Significance of Serum GP73, AFP, and CA199 Test in the Diagnosis of Hepatic Cancer

Dignostic value of GP73 combined with AFP,GGT-II detection on primary liver cancer

Clinical significance of alpha-fetoprotein detection in HBV infectious related diseases

Diagnostic values of plasma Golgi protein-73 and platelet count for different stages of HBV-related liver diseases

Study on the Application Value of Combined Detection of Serum Hepatitis C Virus-Rna Level and Liver Function Indices in Diagnosis and Treatment of Hepatitis C Patients

Clinical Significance of Detection of Serum VEGF,p53 Antibodies and AFP in Patients with HCC

Value of Serum PIVKA-Ⅱ, Alpha-Fetoprotein, and Ferritin in Assisting the Diagnosis of HBV-related Hepatocellular Carcinoma